je.st
news
Tag: survival
New KEYTRUDA (pembrolizumab) Data from KEYNOTE-006 and KEYNOTE-001 in Advanced Melanoma, Including Updated Survival Data, To Be Presented at 2016 ASCO Annual Meeting
2016-05-18 23:19:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Final Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1 Monotherapy to Demonstrate Overall Survival Compared to Ipilimumab, Shows Continued Benefit with Longer Follow-Up KEYNOTE-001 Findings Show Continued Benefit in Response Rates, Duration of Response, and Include New Three-Year Overall Survival Data for KEYTRUDA KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced final overall survival (OS) data from KEYNOTE-006 and new findings from KEYNOTE-001, including updated response rates, duration of response data and three-year OS data with KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in patients with unresectable or metastatic melanoma. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558An Phan, 908-255-6325orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: including
data
advanced
updated
New KEYTRUDA (pembrolizumab) Data at 2016 ASCO Annual Meeting Includes Three-Year Overall Survival Data in Melanoma and Updated Overall Survival Data in Non-Small Cell Lung Cancer As Well As Updated Findings in Head and Neck Cancer
2016-05-16 14:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Data at ASCO Evaluates KEYTRUDA As Single Agent and in Novel Combinations in More Than 15 Different Cancers, Including Several New Tumors KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that new and updated data investigating KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in more than 15 types of cancer will be presented at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 3 7, 2016. Language: English Contact: MerckMedia:Pamela Eisele, (267) 305-3558Kim Hamilton, (908) 740-1863orInvestor:Teri Loxam, (908) 740-1986Justin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Bank branch survival scheme reviewed
2016-05-06 16:58:03| BBC News | Business | UK Edition
An independent review is to be carried out into an agreement to protect remaining bank branches in towns and villages.
Tags: bank
reviewed
branch
scheme
Are there differences in survival among swine corona viruses in feed?
2016-05-02 22:33:00| National Hog Farmer
By Michaela P. Trudeau, Pedro E. Urriola and Gerald C. Shurson, University of Minnesota Department of Animal Science; Harsha Verma, Fernando Sampedro and Sagar M. Goyal, University of Minnesota Department of Veterinary Population Medicine No experiments had been conducted to compare survival kinetics of all three enteric swine coronaviruses simultaneously in feed and feed ingredients for swine. Until now. read more
Tags: in
feed
differences
survival
Maplewood Commuters Beware: NJ Transit Strike Survival Guide
2016-03-07 22:02:20| Railroads - Topix.net
Commuters in the Essex and Hudson County areas are joining others around the state and preparing for a possible NJ Transit railway worker strike that may wreak havoc on thousands of riders' daily schedules and routines. It's been more than 30 years since the last work stoppage at New Jersey Transit.
Tags: guide
strike
survival
transit
Sites : [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] next »